Clinical Trials Directory

Trials / Completed

CompletedNCT02975999

Use of Vasopressin Following the Fontan Operation

Use of Vasopressin Following the Fontan Operation: Both Pilot and Multicenter Studies

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Months – 7 Years
Healthy volunteers
Not accepted

Summary

The purpose of this pilot study is to prepare for a larger study to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.

Detailed description

A pilot randomized, double blinded clinical trial to evaluate the use of vasopressin following the Fontan operation. Phase one of the study will be a single center pilot study and will be conducted at Advocate Children's Hospital, Oak Lawn IL. This will be a randomized and double blinded. Ten patients will be enrolled with five patients as control group and five receiving Vasopressin. Vasopressin levels will be obtained just prior to initiation of Vasopressin and 48 hours later in the pilot study. Safety and effect size will be evaluated after this pilot study. Drug administration protocol: Vasopressin at a dose of 0.4 mU/kg/min will be started on subjects in the study group while coming off cardiopulmonary bypass. The dose of Vasopressin will not be titrated. Study drug drip will infuse for 48 hours after which will be discontinued. The placebo group will be receiving normal saline at the same rate of the vasopressin group. The treating physician will be blinded.

Conditions

Interventions

TypeNameDescription
DRUGVasopressinVasopressin at dose of 0.4mU/kg/min will be started on the assigned group once coming off cardiopulmonary bypass following the Fontan operation.
DRUGNormal SalineNormal saline at starting dose of 0.4mU/kg/min will be started on the assigned group once coming off cardiopulmonary bypass following the Fontan operation.

Timeline

Start date
2016-12-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2016-11-29
Last updated
2024-10-24
Results posted
2024-10-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02975999. Inclusion in this directory is not an endorsement.